
Opinion|Videos|July 29, 2024
Clinical Pearls for Community Oncologist Treating LR-MDS
Author(s)Guillermo Garcia-Manero, MD
Guillermo Garcia-Manero, MD, provides advice to community oncologists on the treatment of anemia for patients with lower-risk MDS.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What clinical pearls could you share to community oncologists in the treatment of anemia for patients with LR-MDS?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5


















